-
1
Oncogenic processes: a neglected parameter in the evolutionary ecology of animals
Published 2024-11-01Get full text
Article -
2
Oncogenic PIK3CA corrupts growth factor signaling specificity
Published 2024-12-01“…Using this framework, we found that the PIK3CA H1047R oncogene was not a simple, constitutive activator of the pathway as often presented. …”
Get full text
Article -
3
Impact of R-loops on oncogene-induced replication stress in cancer cells
Published 2023-09-01Subjects: Get full text
Article -
4
Oncogenic RIT1 mutations confer ferroptosis vulnerability in lung adenocarcinoma
Published 2025-02-01Subjects: Get full text
Article -
5
Comprehensive landscape and oncogenic role of extrachromosomal circular DNA in malignant biliary strictures
Published 2025-02-01Get full text
Article -
6
Key oncogenes and candidate drugs for hepatitis-B-driven hepatocellular carcinoma progression
Published 2025-02-01Get full text
Article -
7
How Do Trematodes Induce Cancer? A Possible Evolutionary Adaptation of an Oncogenic Agent Transmitted by Flukes
Published 2025-01-01Subjects: Get full text
Article -
8
-
9
PTOV1 exerts pro-oncogenic role in colorectal cancer by modulating SQSTM1-mediated autophagic degradation of p53
Published 2025-02-01“…Conclusion Our study unveils the oncogenic role of PTOV1 in CRC progression, which was achieved by promoting SQSTM1 directed autophagic degradation of p53. …”
Get full text
Article -
10
Exploiting somatic oncogenic driver alterations in a patient with Li-Fraumeni syndrome– paving the path towards precision medicine: a case report
Published 2025-01-01“…Conclusions In the era of accessible and comprehensive genetic and phenotypic tumor profiling, this case study of a patient with Li-Fraumeni syndrome underscores the success of precision oncology in harnessing additional somatic oncogenic driver alterations. Furthermore, it emphasizes the indispensable role of an interdisciplinary molecular tumor board, enhancing the awareness of molecular profiling and targeted therapies in patients with rare cancer susceptibility disorders.…”
Get full text
Article -
11
Unlocking nature’s pharmacy: an in-depth exploration of phytochemicals as potential sources of anti-cancer and anti-inflammatory molecules
Published 2024-10-01Subjects: Get full text
Article -
12
-
13
Production of novel theranostic nano-vector based on superparamagnetic iron oxide nanoparticles/miR-497 targeting colorectal cancer
Published 2025-02-01Subjects: Get full text
Article -
14
Diagnostic Accuracy of Next Generation Sequencing Panel using Circulating Tumor DNA in Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Published 2020-09-01“…The aim of the study was to carry out a systematic review and a meta-analysis in order to determine the accuracy of NGS of ctDNA to detect six oncogenic driver alterations: epidermal growth factor receptor (EGFR); anaplastic lymphoma kinase (ALK); ROS proto-oncogene 1, receptor tyrosine kinase (ROS-1); serine/threonine-protein kinase B-RAF (BRAF); RET proto-oncogene (RET); and MET proto-oncogene, receptor tyrosine kinase (MET) exon 14 in patients with aNSCLC. …”
Get full text
Article -
15
Melanoma genomics – will we go beyond BRAF in clinics?
Published 2024-09-01“…However, evaluating the oncogene BRAF mutation in codon V600 is still the only companion diagnostic genomic test commonly implemented in clinics for molecularly targeted treatment of advanced melanoma. …”
Get full text
Article -
16
Natural products as anticancer agents and enhancing their efficacy by a mechanism-based precision approach
Published 2024-07-01“…In this review, I have discussed a limited number of targets including non-oncogene addiction genes such as Sp transcription factors, reactive oxygen species (ROS) or the orphan nuclear receptor 4A (NR4A) sub-family. …”
Get full text
Article -
17
Inhibition of lanosterol synthase linking with MAPK/JNK signaling pathway suppresses endometrial cancer
Published 2025-02-01“…These findings establish LSS as a novel oncogene in EC, promoting tumor progression through MAPK/JNK signaling activation and cholesterol ester accumulation, and highlight the therapeutic potential of targeting LSS in EC treatment.…”
Get full text
Article -
18
Distinct roles of Constitutive Photomorphogenesis Protein 1 homolog (COP1) in human hepatocyte models
Published 2025-02-01“…Prior work in hepatocyte-derived tumors categorized COP1 as an oncogene, but its role in untransformed hepatocytes remains largely unexplored. …”
Get full text
Article -
19
A Bibliometric Analysis of Medullary Thyroid Carcinoma From 2000 to 2022
Published 2024-07-01“…The key areas of focus in highly cited literature were RET proto oncogene, targeted therapy, RET gene mutation, and so on.ConclusionsIn the past 20 years, MTC related research has shown a gradual upward trend, with developed countries led by the United States taking a leading position in this field. …”
Get full text
Article -
20
Nrf2/cyclooxygenase 2 signaling in Cr(VI)-induced carcinogenesis
Published 2025-02-01“…In summary, our study revealed the oncogenic role of COX-2 and identified two novel regulatory mechanisms for COX-2 overexpression in Cr(VI)-induced carcinogenesis.…”
Get full text
Article